ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Orchard Therapeutics Announces OTL-200 Granted RMAT Designation
January 21, 2021Orchard Therapeutics announced the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to OTL-200, an investigational ex vivo autologous hematopoietic stem cell (HSC) gene therapy for the ... -
Orchard Therapeutics Announces MAA Filing of Metachromatic Leukodystrophy Treatment
December 30, 2019Orchard Therapeutics announced the European Medicines Agency (EMA) has validated the company’s Marketing Authorization Application (MAA) for OTL-200 ...
Pharma Sources Insight January 2025
